Page 106 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

82 David S. Younger

[68] Dillon, M. J., Eleftheriou, D., Brogan, P. A. Medium-size-vessel vasculitis. Pediatr.
Nephrol. 2010; 25:1641-1652.

[69] De Rosa, G., Pardeo, M., Rigante, D. Current recommendations for the pharmacologic
therapy in Kawasaki syndrome and management of its cardiovascular complications.
Eur. Rev. Med. Pharmacol. Sci. 2007; 11:301-308.

[70] Burns, J. C., Glode, M. P. Kawasaki syndrome. Lancet 2004; 364:533-544.
[71] Japan Kawasaki Disease Research Committee. Diagnostic guidelines for Kawasaki

disease. 5th Ed. Tokyo, 2002; http://www.kawasaki-disease.org/diagnostic/index.html.
[72] Newburger, J. W., Takahashi, M., Gerber, M. A., et al. Diagnosis, treatment and long-

term management of Kawasaki disease: a statement for health professionals from the
Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on
Cardiovascular Disease in the Young. Pediatrics 2004; 114:1708-1733.
[73] Saundankar, J., Yim, D., Itotoh, B., et al. The epidemiology and clinical features of
Kawasaki disease in Australia. Pediatrics 2014; 133:e1009-e1014.
[74] Lin, Y. T., Manlhiot, C., Ching, J. C., et al. Repeated systematic surveillance of
Kawasaki disease in Ontario from 1995 to 2006. Pediatr. Int. 2010; 52:699-706.
[75] Ma, X. J., Huang, M., Chen, S. B., et al. Epidemiologic features of Kawasaki disease in
Shanghai from 2003 through 2007. Chin. Med. J. 2010; 123:2629-2634.
[76] Li, X. H., Li, H. J., Xu, M., et al. Epidemiological survey of Kawasaki disease in
Sichuan Province of China. J. Trop. Pediatr. 2008; 54:133-136.
[77] Du, A.-D., Zhao, D., Du, J., et al. Epidemiologic study on Kawasaki disease in Beijing
from 2000 through 2004. Pediatr. Infect. Dis. J. 2007; 26:449-451.
[78] Fischer, T. K., Holman, R. C., Yorita, K. L., et al. Kawasaki syndrome in Denmark.
Pediatr. Infect. Dis. J. 2007; 26:411-415.
[79] Holman, R. C., Christensen, K. Y., Belay, E. D., et al. Racial/ethnic differences in the
incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med. J. 2010; 69:
194-197.
[80] Ng, Y. M., Sung, R. Y., So, L. Y., et al. Kawasaki disease in Hong Kong, 1994 to 2000.
Hong Kong Med. J. 2005; 11:331-335.
[81] Singh, S., Aulakh, R., Bhalla, A. K., et al. Is Kawasaki disease incidence rising in
Chandigarh, North India? Arch. Dis. Child. 2011; 96:137-140.
[82] Nakamura, Y., Yashiro, M., Uehara, R., et al. Epidemiologic features of Kawasaki
disease in Japan: results of the 2009-2010 nationwide survey. J. Epidemiol. 2012; 22:
216-221.
[83] Park, Y. W., Han, J. W., Hong, Y. M., et al. Epidemiologic features of Kawasaki
disease in Korea, 2006-2008. Pediatr. Int. 2011; 53:36-39.
[84] Schiller, B., Fasth, A., Bjorkhem, G., et al. Kawasaki disease in Sweden: incidence and
clinical features. Acta Pediatr. 1995; 84:769-774.
[85] Lue, H.-C., Chen, L.-R., Lin, M.-T., et al. Epidemiologic features of Kawasaki disease
in Taiwan, 1976-2007: Results of five nationwide questionnaire hospital surveys.
Pediatr. Neonatol. 2013 Oct. 10 [Epub. ahead of print].
[86] Huang, W. C., Huang, L. M., Chang, I. S., et al. Epidemiologic features of Kawasaki
disease in Taiwan, 2003-2006. Pediatrics 2009; 123:e401-e405.
[87] Harnden, A., Alves, B., Sheikh, A. Rising incidence of Kawasaki disease in England:
analysis of hospital admission data. BMJ 2002; 324:1424-1425.

Complimentary Contributor Copy